Staff Writer
The San Jose, Calif.-based enterprise software developer raised a $56.3 million IPO
The company, which focuses on debilitating infection of the colon, raised a $133.7 million IPO
The Los Angeles-based pharmaceutical company raised a $20 million IPO
The company, which develops drugs to treat cystic fibrosis, raised $77 million in its IPO
The maker of surgucal devices raised $48 million in its IPO and is backed by Kleiner Perkins, among others
The ophthalmic med tech company held a $108 million IPO
The maker of the popular health and fitness trackers, held a $731 million IPO, vaulting its market cap to $7.8 billion by month’s end
The healthcare company raised $195.50 million in its IPO
The Georgian company, which provides glycemic index endoscopy products and services, held a $95.3 million IPO
The biopharmaceutical company held a $60 million IPO